Selective stimulation to modulate the sympathetic nervous system

a technology of sympathetic nervous system and selective stimulation, applied in the direction of spinal electrodes, internal electrodes, therapy, etc., can solve the problems of pain, dysfunction, social problems, and ultimately death, and reduce the effect of neuromodulation of other neurons, reducing or eliminating undesired side effects, and pain tingling or unwanted movements

Inactive Publication Date: 2012-11-01
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV +1
View PDF6 Cites 50 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0008]The present invention provides targeted treatment of a variety of medical conditions by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies. In preferred embodiments, the target anatomy includes one or more dorsal root ganglia, dorsal roots, dorsal root entry zones, or portions thereof. Such target stimulation areas are utilized due in part to their effect on the sympathetic nervous system. In particular, many of these target anatomies house sensory fibers that are isolated from motor fibers. Sensory fibers are involved in a variety of reflexes and feed-forward physiologic processes that control the sympathetic nervous system and these reflexes and processes can be utilized in the treatment of various disorders. In addition, in some embodiments, such targeted neuromodulation reduces or eliminates undesired side effects, such as painful tingling or unwanted movements caused by direct stimulation of motor nerves, such as within the ventral root. Further, such targeted therapy minimizes or eliminates global activation or inactivation of the sympathetic nervous system and the complications that arise from such activation or inactivation.

Problems solved by technology

A variety of diseases and medical conditions plague the population causing pain, dysfunction, distress, social problems, and ultimately death.
However, many of these treatments cause adverse effects in addition to or in place of the intended therapeutic effect.
The severity of adverse effects can range from nausea to death.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Selective stimulation to modulate the sympathetic nervous system
  • Selective stimulation to modulate the sympathetic nervous system
  • Selective stimulation to modulate the sympathetic nervous system

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0027]The sympathetic system is responsible for mobilizing the body's responses under stressful situations, also known as the ‘flight or fight’ response. The sympathetic system acts on many different organs of the body including the eyes (contraction and dilation of the pupils), heart (increase in heart rate, blood flow, blood pressure), lungs (dilation of bronchioles), digestive system (inhibiting movement of food), kidney (increase secretion of rennin), and penis (promote ejaculation). The sympathetic system is also active at a basal level on these and many organs so as to maintain a state of homeostasis in the body.

[0028]Given the unique role of the sympathetic system in the body and the ability of the sympathetic system to affect a wide array of internal organs, the sympathetic system may be utilized to treat a variety of conditions throughout the body. Such conditions include, but are not limited to, ischemic disorders, diabetes, peripheral vascular disease, stroke, erectile dy...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Systems, methods and devices are provided for the targeted treatment of a variety of medical conditions by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies. Typically, the target anatomy includes one or more dorsal root ganglia, dorsal roots, dorsal root entry zones, or portions thereof. Such target stimulation areas are utilized due in part to their effect on the sympathetic nervous system.

Description

CROSS-REFERENCES TO RELATED APPLICATIONS[0001]This application claims priority under 35 U.S.C. 119(e) to U.S. Provisional Patent Application No. 61 / 480,958, entitled “Selective Stimulation of Dorsal Root Ganglion to Modulate the Sympathetic Nervous System”, filed on Apr. 29, 2011, which is incorporated by reference in its entirety. This application is also a continuation-in-part of U.S. patent application Ser. No. 12 / 369,706, entitled “Methods of Stimulating a Dorsal Root Ganglion”, filed on Feb. 11, 2009, now U.S. Publication No. US-2009-0210041-A1, which is a divisional of U.S. patent application Ser. No. 11 / 222,516, entitled “Methods for Stimulating a Dorsal Root Ganglion”, filed on Sep. 7, 2005, now U.S. Pat. No. 7,502,651, which claims priority under 35 U.S.C. 119(e) to U.S. Provisional Patent Application No. 60 / 608,357, entitled “Neurostimulation Systems and Methods”, filed on Sep. 8, 2004, all of which are incorporated herein by reference in their entirety.STATEMENT AS TO RIG...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61N1/05
CPCA61N1/0551A61N1/36071A61N1/36057A61N1/36135A61N1/36114
Inventor KRAMER, JEFFERY M.KIM, DANIEL H.IMRAN, MIR A.
Owner THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products